The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Nanoscale Mixed-Ligand Metal–Organic Framework for X-ray Stimulated Cancer Therapy
Abstract
Concurrent localized radiotherapy and systemic chemotherapy are standards of care for many cancers, but these treatment regimens cause severe adverse effects in many patients. Herein, we report the design of a mixed-ligand nanoscale metal–organic framework (nMOF) with the ability to simultaneously enhance radiotherapeutic effects and trigger the release of a potent chemotherapeutic under X-ray irradiation. We synthesized a new functional quaterphenyl dicarboxylate ligand conjugated with SN38 (H 2 QP-SN) via a hydroxyl radical-responsive covalent linkage. Because of the similar length of QP-SN and bis( p -benzoato)porphyrin (DBP) ligands, QP-SN was incorporated into Hf-DBP nMOF to afford a novel multifunctional mixed-ligand Hf-DBP-QP-SN nMOF with good biocompatibility. Hf-DBP-QP-SN not only enhances radiation damage to tumors via a unique radiotherapy-radiodynamic therapy (RT-RDT) process but also increases ·OH generation from radiolysis with electron-dense Hf 12 secondary building units (SBUs) to release SN38 from Hf-DBP-QP-SN for chemotherapy. Elevated levels of hydrogen peroxide in the tumor microenvironment further stimulate the release of SN38 by enhancing ·OH generation under X-ray irradiation. With low doses of X-ray irradiation, Hf-DBP-QP-SN suppressed the growth of CT26 colon and 4T1 breast tumors by 93.5% and 95.2%, respectively, without any sign of general toxicity. Our study highlights the potential of using ionizing radiation-mediated chemistry for on-demand activation of nanotherapeutics for synergistic radiotherapy and chemotherapy without causing severe adverse effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, Zhen et al. developed a mixed-ligand Hf-based nanoscale MOF (Hf-DBP-QP-SN) that combined radiotherapy enhancement, radiodynamic therapy, and X-ray-triggered release of the chemotherapeutic SN38. In a 4T1 breast cancer model, this platform achieved 95.2% tumor growth suppression under low-dose irradiation without evidence of systemic toxicity, illustrating the potential of ionizing”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [94]
Citations
Cites
Clonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Chemotherapy and the war on cancer
Chabner, B. A., & Roberts, T. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1529 · Cited by 2,154
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
Della Rocca, J., Liu, D., & Lin, W. (2011) · Accounts of Chemical Research · doi:10.1021/ar200028a · Cited by 2,087
Self-citationRecent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Yang, G., Xu, L., Chao, Y., Xu, J., Sun, X., Wu, Y., Peng, R., & Liu, Z. (2017) · Nature Communications · doi:10.1038/s41467-017-01050-0 · Cited by 1,477
BioMOFs: Metal–Organic Frameworks for Biological and Medical Applications
McKinlay, A. C., Morris, R. E., Horcajada, P., Férey, G., Gref, R., Couvreur, P., & Serre, C. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000048 · Cited by 1,256
He, C., Liu, D., & Lin, W. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00125 · Cited by 1,001
Self-citationMetal–organic frameworks as potential drug carriers
Huxford, R. C., Della Rocca, J., & Lin, W. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.12.012 · Cited by 840
Self-citationLo, P.-C., Rodríguez-Morgade, M. S., Pandey, R. K., Ng, D. K. P., Torres, T., & Dumoulin, F. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00129h · Cited by 752
Research works printed but not linked: 2
- Bottero V., 2001, Cancer Res., 61, 7785
- 10.1002/1097-0142(19910115)67:2<421::aid-cncr2820670217>3.0.co;2-q · doi:10.1002/1097-0142(19910115)67:2<421::aid-cncr2820670217>3.0.co;2-q
Cited by
Metal‐Organic Framework‐Based Nanomaterials for Biomedical Applications
Lu, X., He, S., Han, Z., Guo, X. L., Pan, X., Zhou, Y., Zhou, Z., & Tan, C. (2025) · SmartMat · doi:10.1002/smm2.70055 · Cited by 75
Thermal‐Adaptive Photonic MOFs for High‐Performance X‐ray Scintillator
Li, H., Dong, Q., Li, Y., Hu, E., Cai, Y., Zhang, L., Zhao, D., Guo, H., & Qian, G. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202500445 · Cited by 38
Qin, J., Jiang, K., Yuan, Z., Zhang, L., & Chen, B. (2025) · ACS Nano · doi:10.1021/acsnano.5c12462 · Cited by 30
Radiotherapy-Activated Prodrug: Past, Present and Beyond
Wang, C., Zhang, Z., & Liu, Z. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c00875 · Cited by 26
Zhen, W., Zhao, T., Chen, X. S., & Zhang, J. (2025) · Small · doi:10.1002/smll.202500880 · Cited by 24
Self-citationGong, B., Zhang, Q., Qu, Y., Zheng, X., & Wang, W. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070883 · Cited by 13
Li, Y., Jin, L., Tao, B., Li, X., Shi, H., Qin, Y., Hao, Y., Li, Q., Feng, Q., Li, T., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07277-6 · Cited by 17
Metal-organic framework-based radiosensitizer for cancer therapy
Xie, Y., Xu, Y., Liu, Y., Mei, Z., & Tian, J. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217103 · Cited by 12
The role of ionizing radiation-initiated reactions in targeted activation of chemotherapeutics
Liu, J., Denkova, A. G., & Eelkema, R. (2025) · Nature Reviews Chemistry · doi:10.1038/s41570-025-00779-3 · Cited by 14
Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy
Tu, Z., Sang, Z., Yang, X., Liang, W., Qiao, S., Sun, Q., Feng, K., Kong, Z., Wang, H., & Liu, Z. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c17573 · Cited by 11
Mao, Y., Tillman, L., Jiang, X., Bian, W., Wang, C., Fromme, T., Weichselbaum, R. R., & Lin, W. (2025) · Chemical Science · doi:10.1039/d5sc03446a · Cited by 12
Self-citationNanomedicine strategies for disulfidptosis activation in SLC7A11-high tumors
Ye, Z., Yao, Y., Xu, Y., Ye, J., Yao, Q., Kou, L., & Chen, R. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115094 · Cited by 11
Zheng, Y., Chu, B., Chen, D., Shao, B., Nian, H., Chen, Z., Li, F., Lu, Y., Li, L., Huang, N., et al. (2025) · Small · doi:10.1002/smll.202505324 · Cited by 10
Xiao, W., Yang, X., Wang, M., Jiang, Z., Zhang, H., Gong, M., Zhao, L., Song, J., & Fu, Q. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03531-7 · Cited by 8
Li, Y., Shan, J., Liu, S., Shen, Y., Niu, L., Mao, Q., & Chen, X. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167958 · Cited by 8
Cao, Y., Zheng, M., Zhou, Q., Dong, Y., Hou, Y., & Ge, Z. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c11614 · Cited by 8
Yu, Z., Chivu, A., Dai, J., Li, Z., Hu, S., Huang, R., Patra, H. K., Zou, J., & Hu, Z. (2025) · Applied Catalysis B: Environmental · doi:10.1016/j.apcatb.2025.126259 · Cited by 7
Defect-engineered metal-organic framework as a universal platform for theranostic applications
Yang, S., Xiong, X., Zhong, Q., Xian, S., Jiang, Y., Hou, Y., Xiao, Z., Xiao, H. P., & Shuai, X. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124213 · Cited by 4
Optical imaging probes for mitochondrial metabolism: Mechanism, design and frontier applications
Yuan, S., Zhao, Y., Liu, S., Gao, Y., He, L., & Liu, S. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.217570 · Cited by 3
Zhen, W., Jiang, X., Li, E., Germanas, T., Lee, M. J., Luo, T., Ma, X., Wang, C., Chen, Y., Weichselbaum, R. R., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123355 · Cited by 4
Self-citationLi, H.-J., Wang, F., Zhang, X., Liang, B., Chen, Y., Chenxiang, Y., Liao, Q., Xue, F., Wang, D., & He, B. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.138700 · Cited by 3
Lunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
Recent Progress in the Development of Metal‐Based Radiosensitizations for Cancer Therapy: A Review
Wu, X., Zhang, D., Hu, C., Ding, Y., Chen, K., Jiang, Y., Luo, J., Cao, F., Hao, W., Zhong, B., et al. (2025) · Rare Metals · doi:10.1002/rar2.70039 · Cited by 2
Nash, G. T., Zhen, W., Li, J., Jiang, X., Wang, C., Weichselbaum, R. R., & Lin, W. (2025) · Chemistry of Materials · doi:10.1021/acs.chemmater.5c01462 · Cited by 2
Self-citationChen, Y., Zhou, Z., Wang, D., Liu, C., Mo, C., Tian, S., Wu, Y., & Song, J. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123918 · Cited by 1
Surface-Confinement Effect Enables Bioorthogonal Drug Release in Tumors
Tu, Z., ZiYang, S., Xu, Y., Ao, J., Chen, Y., Liang, W., Chen, J., & Liu, Z. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c10046 · Cited by 1
Jiang, J., Zhang, T., Dong, J., & Sun, W. (2026) · Advanced Science · doi:10.1002/advs.77450
Bird-Inspired Time-Domain Analysis: High-Robustness Intelligent Sensing of Hypochlorite Aerosols
Yang, X., Chen, C., Wang, D., Yan, X., Zhang, L., Yang, F., & Lv, Y. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c03485
Shen, X., Xi, J., Gao, R., Li, Y., & Liu, J. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.139802
Guan, Q., Zhou, L., Zhou, W., Yang, Z., Chen, B., Li, Y., & Wang, R. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c07767
Fu, N., Guo, L., Zhan, Z., Chen, Z., Chen, J., Li, Q., Li, J., He, G., Zheng, Y., & Zhang, D. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04883-4
Nano-Radiosensitizers for Radiotherapy: Design Strategies and Antitumor Immune Responses
Song, R., & Lin, W. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00136
Self-citationZheng, Y., Li, L., Fu, W., Li, Y., Yan, J., Chi, X., 尹震宇, Lin, H., & Gao, J. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c13187
Rewiring Biological Barriers in Pancreatic Diseases with Metal–Organic Frameworks
Li, H., Hou, J., He, C., Liu, C., Ran, B., Song, X., Lin, L., Bao, L., Zhao, Y., Mu, J., et al. (2026) · Biology · doi:10.3390/biology15191783
Shou, Y., Liu, Y., Zhao, X., Xu, Z., Bai, X., Gao, F., Li, Z., & Wang, Y. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s639374
Self-citationRegulated cell death-based nanoplatforms for radiosensitization in cancer therapy
Chen, Y., Zhang, L., & Zou, R. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.183169
Xiao, T., Luo, Y., Liu, X., Wang, L., & Yin, X.-B. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100692
Song, R., Li, J., Wang, C., Tillman, L., Mao, Y., Xiong, Y., Li, X., Weichselbaum, R. R., & Lin, W. (2026) · Science Advances · doi:10.1126/sciadv.aeh5903
Self-citation
Metadata
- Authors
- Zhen, W., Xu, Z., Mao, Y., McCleary, C., Jiang, X., Weichselbaum, R. R., & Lin, W.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Lin, Wenbin
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2024-11-20
- Volume
- 146
- Issue
- 48
- Pages
- 33149-33158
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W4404560679
- Cited by
- 37
- References
- 66
- Citations by year
- 2026: 12 · 2025: 25
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of the American Chemical Society (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (1R01CA253655, P30 CA014599)
- Ludwig Institute for Metastasis Research
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Organic Frameworks: Synthesis and Applications
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- metal-organic frameworks, X-ray irradiation, radiotherapy, chemodynamic therapy, SN-38, hydroxyl radical generation, hydrogen peroxide, tumor microenvironment, colon cancer, breast cancer, on-demand drug release
- MeSH terms
- Metal-Organic Frameworks, Animals, Antineoplastic Agents, Humans, Ligands, X-Rays, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.